The Fair Work Commission has found that a salary packaging provider had âreasonable business groundsâ to force workers back to the office, rejecting an employeeâs bid to work full-time from home.Â
A judge has rejected McDonald’s claim that Hungry Jack’s Big Jack burger infringed its Big Mac trade mark, but found that Hungry Jack’s misled consumers by boasting that its burger had 25 per cent more beef.
Qantas has been found guilty of a safety violation for standing down a worker who raised concerns about unsafe work conditions during the early days of the coronavirus pandemic.
A judge has upheld a ruling that rejected a bid by two class actions against Victorian aged care providers for insurance and financial information, finding the court likely does not have the power to order the production of documents that are not relevant to the proceeding.
Grocon has taken another hit in its $270 million lawsuit against Infrastructure NSW over a stalled $2 billion Central Barangaroo development project, with a judge rejecting its claim of privilege over more than 15,000 documents.
A leading class action firm may seek compensation for those who were illegally detained after the High Court ruled that Australia’s system of holding individuals indefinitely in immigration detention is unlawful.
A Sydney lawyer has been ordered to pay the costs of a property dispute after a judge found his conduct meant the case was âdoomed to failâ and caused the costs of the litigation to be wasted.
A human rights group has lost its legal bid to compel the federal government to bring home Australians stuck in Syrian camps, with a a judge finding the Minister for Home Affairs has âno controlâ over their detention.
Tiwi Islanders have won an eleventh hour bid to halt all work on Santos’ Barossa gas export pipeline for one week, with a judge finding construction could cause “irreparable damage” to underwater cultural heritage.
Novartis unit Sandoz AG has lost its bid to revoke Bayerâs patents for its top-selling blood clot drug Xarelto and has been barred from selling generic versions of the medication after a judge found the German pharma giantâs patents were valid.